SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ore Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (18)7/31/2008 10:17:31 PM
From: Mike McFarlandRead Replies (1) | Respond to of 50
 
(I'll listen to the archive when I get a chance over
the weekend--I'll be sleeping off a graveyard when they
start the call)

Ore Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 1, 2008
GAITHERSBURG, Md., Jul 29, 2008 (BUSINESS WIRE) -- Ore Pharmaceuticals Inc. (NASDAQ:ORXE) announced today that it will release second quarter 2008 financial results on Friday, August 1, 2008 at 6:00 a.m. Eastern Time, before the open of the U.S. financial markets.

The Company will hold a related conference call and webcast, scheduled for 10:00 a.m. Eastern Time on the same day, to discuss the financial results. The conference call will be open to investors, analysts, members of the media, and the general public.

Conference Call Details:
----------------------------------------------------------------------
Dial-In: 866.761.0748 Domestic
617.614.2706 International
Passcode: 61258077
Replay Dial-In: 888.286.8010 Domestic
617.801.6888 International
Passcode: 12649862
Available through August 15, 2008

Webcast: Please go to
orepharma.com
within 15 minutes prior to the call and select
the webcast link.

An archived webcast of the conference call will also be available under the Investors section of the Company's website at www.orepharma.com.



To: Mike McFarland who wrote (18)8/7/2008 12:51:19 PM
From: Mike McFarlandRead Replies (1) | Respond to of 50
 
Ore Pharmaceuticals Acquires Rights to Develop a Second Drug Candidate from Roche

Ore Pharmaceuticals Files for Patents, Plans to Develop and Out-License Candidate for Metabolic Conditions Such as Obesity or High Cholesterol

phx.corporate-ir.net;

romazarit modulates a key pathway related to metabolic function